Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DEVICE USER FEES SHOULD BE PROTECTED FROM DEFICIT REDUCTION USE

This article was originally published in The Gray Sheet

Executive Summary

DEVICE USER FEES SHOULD BE PROTECTED FROM DEFICIT REDUCTION USE through a "carefully crafted" user fee bill, Rep. John Dingell (D-Mich.) declared July 14 at a House Energy and Commerce/Health Subcommittee hearing on medical device user fee legislation. User fees, according to the Energy and Commerce Committee chairman, must be insulated from the "constant pressure" of "the administration generally and others to get that money and to divert it into general budgetary purposes."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel